Source: International Congress 2015 – Systemic and airway biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Tetiana Bondarenko (Ivano-Frankivsk, Ukraine), Mykola Ostrovskyy, Tetiana Bondarenko, Oleksandr Varunkiv. Dynamics of the inflammatory process by determining the IL-6 content in bronchoalveolar fluid in chronic bronchitis and chronic bronchitis complicated by secondary bronchiectasis. Eur Respir J 2015; 46: Suppl. 59, 3875

Member's Comments

No comment yet.

Related content which might interest you: The dynamics of IV-type collagen contens in balf of patients with chronic bronchitis and chronic bronchitis complicated with secondary bronchiectasis Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies Source: Eur Respir J 2008; 31: 70-77 Year: 2008 Chronic bronchitis: a risk factor for bronchial infection Source: Eur Respir Monogr 2013; 60: 18-26 Year: 2013 Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis Source: Eur Respir J 2012; 39: 1354-1360 Year: 2012 Pathology of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=159 Year: 2006 Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Changes in bronchial inflammation during acute exacerbations of chronic bronchitis Source: Eur Respir J 2001; 17: 1112-1119 Year: 2001 Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design Source: Eur Respir J 2006; 27: 293-299 Year: 2006 Resolution of bronchial inflammation during exacerbations of chronic bronchitis relate to changes in bacteriology. Source: Eur Respir J 2002; 20: Suppl. 38, 592s Year: 2002 Induced sputum cytology at different etiology of exacerbation of chronic obstructive bronchitis Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002 Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001 Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Exacerbation aetiology and inflammation markers in chronic obstructive bronchitis Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002 Clinical and temporal characteristics of chronic bronchitis complicated with secondary bronchiectasis Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations Source: Annual Congress 2005 - COPD: role of infection Year: 2005 Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Management of chronic airway infection in bronchiectasis Source: Virtual Congress 2020 – The future of bronchiectasis management Year: 2020 Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015